Management of the migraine patient.
Migraine is among the most common disorders seen in office practice. Some epidemiologists believe it may occur in up to 25 percent of the general population. Pharmacologic treatment and behavior therapy, as well as a stable physician-patient relationship, are important factors in reducing the frequency and severity of recurrent head pain. Benefits of migraine therapy include improvements in the patient's overall health and sense of well-being.
D000639:Amitriptyline / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004032:Diet; D004878:Ergotamine / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008784:Methysergide / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D010100:Oxygen / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013312:Stress, Physiological / Q000150:complications; D014700:Verapamil / Q000627:therapeutic use
D000700:Analgesics; D006993:Hypnotics and Sedatives; D000639:Amitriptyline; D011433:Propranolol; D014700:Verapamil; D008787:Metoclopramide; D004878:Ergotamine; D010100:Oxygen; D008784:Methysergide